Results 21 to 30 of about 84,586,414 (211)

Involvement of 5-HT2A receptor hyperfunction in the anxiety-like behavior induced by doxorubicin and cyclophosphamide combination treatment in rats

open access: yesJournal of Pharmacological Sciences, 2018
We examined whether combination treatment with doxorubicin and cyclophosphamide, a traditional chemotherapy for breast cancer, induced anxiety-like behavior in rats.
Yuka Nakamura   +8 more
doaj   +1 more source

Htr2a gene and 5-HT2A receptor expression in the cerebral cortex studied using genetically modified mice

open access: yesFrontiers in Neuroscience, 2010
Serotonin receptors of the 5-HT2A subtype are robustly expressed in the cerebral cortex where they have been implicated in the pathophysiology and therapeutics of mental disorders and the actions of hallucinogens.
Rodrigo Andrade, Elaine T Weber
doaj   +1 more source

Cortical 5‐HT2A receptor density predicts 5‐HT2A receptor mediated behavior in the rabbit

open access: yesThe FASEB Journal, 2006
Serotonin 5‐HT 2 receptor agonists such as DOI [1(2, 5‐dimethoxy‐4‐iodophenyl)‐2‐aminopropane] injected systemically or directly into frontal cortex, elicit stereotyped head movements that are mediated by 5‐HT 2A receptors.
Kuldip D Dave   +2 more
openaire   +1 more source

Disruption of 5-HT2A receptor-PDZ protein interactions alleviates mechanical hypersensitivity in carrageenan-induced inflammation in rats. [PDF]

open access: yesPLoS ONE, 2013
Despite common pathophysiological mechanisms, inflammatory and neuropathic pain do not respond equally to the analgesic effect of antidepressants, except for selective serotonin reuptake inhibitors (SSRIs), which show a limited efficacy in both ...
Anne-Sophie Wattiez   +10 more
doaj   +1 more source

5-HT2A Receptor Binding in the Frontal Cortex of Parkinson’s Disease Patients and Alpha-Synuclein Overexpressing Mice: A Postmortem Study

open access: yesParkinson's Disease, 2016
The 5-HT2A receptor is highly involved in aspects of cognition and executive function and seen to be affected in neurodegenerative diseases like Alzheimer’s disease and related to the disease pathology. Even though Parkinson’s disease (PD) is primarily a
Nadja Bredo Rasmussen   +8 more
doaj   +1 more source

Receptor Interaction Profiles of 4-Alkoxy-Substituted 2,5-Dimethoxyphenethylamines and Related Amphetamines

open access: yesFrontiers in Pharmacology, 2019
Background: 2,4,5-Trimethoxyamphetamine (TMA-2) is a potent psychedelic compound. Structurally related 4-alkyloxy-substituted 2,5-dimethoxyamphetamines and phenethylamine congeners (2C-O derivatives) have been described but their pharmacology is mostly ...
Karolina E. Kolaczynska   +5 more
doaj   +1 more source

Regulation of serotonin-induced trafficking and migration of eosinophils. [PDF]

open access: yesPLoS ONE, 2013
Association of the neurotransmitter serotonin (5-HT) with the pathogenesis of allergic asthma is well recognized and its role as a chemoattractant for eosinophils (Eos) in vitro and in vivo has been previously demonstrated.
Bit Na Kang   +7 more
doaj   +1 more source

Altered Serotonin 2A (5-HT2A) Receptor Signaling Underlies Mild TBI-Elicited Deficits in Social Dominance

open access: yesFrontiers in Pharmacology, 2022
Various forms of traumatic brain injury (TBI) are a leading cause of disability in the United States, with the generation of neuropsychiatric complications such as depression, anxiety, social dysfunction, and suicidality being common comorbidities ...
Sean M. Collins   +9 more
doaj   +1 more source

Characterization of the human 5-HT2A receptor gene promoter [PDF]

open access: yesThe Journal of Neuroscience, 1995
The regulation of 5-HT2A receptor (5-HT2AR) expression has been implicated in a variety of pathological processes and has been shown to be extremely complicated and controversial. In order to understand the mechanisms of regulation of this receptor, it is important to characterize its promoter.
Q S, Zhu, K, Chen, J C, Shih
openaire   +2 more sources

Novel Phenylalkylamines as 5‑HT2A Agonists for Treating Psychiatric Disorders. [PDF]

open access: yesACS Med Chem Lett
Provided herein are novel phenylalkylamines as 5-HT2A agonists, pharmaceutical compositions, use of such compounds in treating psychiatric disorders, and processes for preparing such compounds.
Sabnis RW.
europepmc   +3 more sources

Home - About - Disclaimer - Privacy